Information  X 
Enter a valid email address

Stand. Life UK Small (SLS)

  Print      Mail a friend       Annual reports

Friday 17 January, 2020

Stand. Life UK Small

Compliance with Market Abuse Regulation

RNS Number : 2180A
Standard Life UK Small.Co's Tst PLC
17 January 2020


Standard Life UK Smaller Companies Trust plc  

Legal Entity Identifier (LEI):  213800UUKA68SHSJBE37


17 January 2020



Compliance with Market Abuse Regulation


Standard Life UK Smaller Companies Trust plc announces that it is satisfied, by virtue of the points listed below, that all inside information which the Directors and the Company may have in the closed period (as defined by the EU Market Abuse Regulation) which ends on the date of the announcement of the Half-Yearly Report for the six month period ended 31 December 2019 has been notified to a Regulated Information Service ("RIS"). The Company is therefore not prohibited from purchasing its own securities or issuing shares during this period.


In so stating the Company has regard to;


1)  the announcement on 7 January 2020 of the net asset value per share as of the close of business on 31 December 2019,

2)  the Company's belief, following reasonable enquiries, that there will be no material difference between the information published on 7 January 2020 and that to be included in the forthcoming announcement of the Half-Yearly Report,

3)  the Company's practice of calculating net asset values per share each business day and the announcement of these net asset values to an RIS,

4) there being no other unpublished information which constitutes price-sensitive information in respect of the Company's securities, and

5)   there being no unquoted investments within the Company's portfolio.



For further information, please contact:

G Hay Smith

Aberdeen Asset Management PLC

Company Secretary

0131 372 2200



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t